General Mills, Inc. — ROASTED SWEET CORN, HONEY
by General Mills, Inc.MRT 176 Panel Triggers Identified
Clinical Product Assessment
MRT 176 Panel Safety Assessment
Clinical Narrative
The analysis of the provided product name identifies two primary MRT-tested substances: Corn and Honey. As this product contains 1-2 known triggers, it is classified as Moderate Risk. It is unsuitable for the Phase 1 elimination diet but may be appropriate for Phase 2 reintroduction testing, provided the patient has successfully passed both Corn and Honey on their individual MRT results. It should be noted that processed snacks of this nature frequently contain additional unlisted ingredients such as cane sugar or oils, which were not evaluated here.
Flagged Ingredient Mapping
| Ingredient | Maps To (MRT Panel) | Match Type |
|---|---|---|
| roasted sweet corn | Corn | DIRECT_MATCH |
| honey | Honey | DIRECT_MATCH |
This is procedural data interpretation, not medical guidance. Always consult your Certified LEAP Therapist.
Understanding These Triggers
Corn derivatives are among the hardest triggers to avoid. Found as corn syrup, cornstarch, modified food starch, dextrose, maltodextrin, and citric acid in thousands of processed products.
Honey is tested as a distinct substance on the MRT panel. It contains proteins that can trigger mediator release independently of its sugar content. Found in many "natural" sweetened products.
What This Means For Your Diet
With 2 identified triggers, this product falls into the moderate risk category. It may be suitable for Phase 2 reintroduction under practitioner guidance, depending on your individual MRT results.
If the specific triggers identified in this product scored Green on your personal MRT panel, your CLT may approve it for controlled reintroduction. If they scored Yellow or Red, this product should be avoided until cleared.
Full Ingredient List
roasted sweet corn, honey
More from General Mills, Inc.
About This Assessment
This safety assessment was generated by cross-referencing the USDA FoodData Central ingredient record for this product against the 176 substances tested on the Mediator Release Test (MRT) panel. Clinical notes are produced with AI assistance using the matched ingredient data and reviewed by Kerry Watson, NTP, RWP for accuracy against published LEAP ImmunoCalm® protocol guidelines. Risk classifications are based on the number and type of MRT-tested substances identified. This information is for educational purposes only and is not medical advice — always consult your Certified LEAP Therapist before making dietary changes.
Find a LEAP Therapist
Get personalized guidance from a Certified LEAP Therapist in your area.
Browse Practitioners